doi:10.1016/S2213-8587(21)00174-1 Ozempic tablets
Supplementary Table 2 showed the results of subgroup analysis stratified by SGLT2 inhibitors, with acute heart failure as the outcome
According to the researchers, the findings suggest that semaglutide could potentially address both aspects of the condition simultaneously, by improving metabolic health while also supporting reproductive function
Our results are consistent with a post hoc analysis of the EXCEL trial [29] which concluded that exenatide combined with SGLT-2i reduced the risk of MACE (defined as cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke) compared with exenatide monotherapy and also improved eGFR significantly
Currently approved peptide treatments such as semaglutide 2.4 mg (Wegovy) are available under NICE TA875 for adults with BMI 35 kg/m and a weight-related comorbidity, delivered within a specialist weight management service
We will work closely with you, developing a plan thats tailored to your unique needs and goals